Article
HLA-B*15:11 status and carbamazepine-induced severe cutaneous adverse drug reactions in HLA-B*15:02 negative Chinese.
International journal of dermatology - 1 Feb 2022
Wong Christina S M, Yap Desmond Y H, Ip Patrick, Wong Wilfred H S, Chua Gilbert T, Yeung Chi-Keung, Chan Henry H L, Kwok Janette S Y
Abstract excerpt
BACKGROUND: HLA-B*15:11 is associated with carbamazepine (CBZ)-induced severe cutaneous adverse drug reactions (SCARs) in Japanese and some Asian populations, but such data remains relatively limited in Chinese. Routine HLA-B*15:02 screening is mandatory before CBZ commencement, however, SCARs related to CBZ were still observed in non-HLA*B-15:02 carriers. OBJECTIVE: We aimed to find out the prevalence of...
Topics
Join the communities discussing this publication.
